Developmental loss of MeCP2 from VIP interneurons impairs cortical function and behavior

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Rett Syndrome is a severe neurodevelopmental disorder linked to mutations in the Methyl CpG binding protein 2 (MECP2) gene.
• Previous research indicates that defects in GABAergic inhibitory interneurons contribute to Rett Syndrome phenotypes.
• Vasoactive intestinal peptide-expressing (VIP) interneurons are crucial for cortical circuit development and function, but their specific role in Rett Syndrome remains unclear.

Purpose of the Study:

• To investigate the specific role of VIP interneurons in the pathophysiology of Rett Syndrome.
• To determine if loss of MeCP2 function specifically within VIP interneurons is sufficient to cause Rett Syndrome-like neural and behavioral deficits.

Main Methods:

• Utilized mouse models with targeted deletion of the Mecp2 gene in VIP interneurons.
• Assessed neural and behavioral phenotypes in these genetically modified mice compared to controls with global Mecp2 loss of function.

Main Results:

• Loss of MeCP2 specifically in VIP interneurons recapitulated key neural and behavioral phenotypes observed in global Mecp2-deficient mouse models of Rett Syndrome.
• This suggests that VIP interneurons are a critical site of pathology in Rett Syndrome.

Conclusions:

• The findings highlight the significant contribution of VIP interneurons to the complex pathology of Rett Syndrome.
• Targeting MeCP2 dysfunction in VIP interneurons may offer a potential therapeutic avenue for Rett Syndrome.